PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsbone resorption
MeSH D001862 - bone resorption
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001847:Bone diseases
$
Success rate
D016723:Bone remodeling
0 Companies
0 Drugs
Success rate
D001862: 
Bone resorption
$
Success rate
D000387:Ainhum
0 Companies
0 Drugs
Success rate
D010014:Osteolysis
$
Success rate
D016301:Alveolar bone loss
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AmgenDenosumab Prolia  2010-05-26 $4,120 M Q2/23-Q1/24 
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
75%
3/4
Phase 3
71%
5/7
Approved: 3Overall Success rate: 54%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amgen
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use